Clinical Trials Logo

Clinical Trial Summary

The purpose of this study was to test whether ticagrelor combined with aspirin can reduce the recurrence rate of stroke within 3 months compared with clopidogrel combined with aspirin in patients at high risk of non-disablement ischemic cerebrovascular events who carry the CYP2C19 function loss allele within 24 hours of onset.


Clinical Trial Description

This study was a multicenter, double-blind, double-simulated, randomized controlled study. To test whether ticagrelor combined with aspirin reduces the recurrence rate of stroke within 3 months compared with clopidogrel combined with aspirin in patients with a high risk of noncrippling ischemic cerebrovascular events with CYP2C19 loss within 24 hours of onset. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04952311
Study type Interventional
Source Peking University Third Hospital
Contact Yu Fu
Phone +86 15611908699
Email lilac_fu@sina.com
Status Recruiting
Phase Phase 3
Start date June 1, 2019
Completion date September 30, 2021

See also
  Status Clinical Trial Phase
Recruiting NCT00859885 - International PFO Consortium N/A
Not yet recruiting NCT03605355 - Feasibility Study on the Medical and Economic Consequences of Outpatient Management of TIAs and Minor Strokes
Completed NCT03281590 - Stroke and Cerebrovascular Diseases Registry
Completed NCT02905383 - The Effect of Exercise on Physical Function and Health in Older People After Discharge From Hospital N/A
Completed NCT04078737 - Clopidogrel With Aspirin in High-risk Patients With Acute Non-disabling Cerebrovascular Events II Phase 3
Completed NCT02141932 - Pocket-size Cardiovascular Ultrasound in Stroke N/A
Recruiting NCT01954329 - Markers in the Diagnosis of TIA N/A
Completed NCT02011256 - Early Detection Of Atrial Fibrillation In Patients With Transient Ischemic Attack N/A
Completed NCT01918891 - Center for Stroke Disparities Solution - Community Transitions Intervention N/A
Recruiting NCT01526824 - Lovaza's Effect on Clopidogrel in a Neuro Population Phase 0
Completed NCT01020851 - The PREVENTS Trial: The Preventing Recurrent Events in Veterans Navigating Transient Ischemic Attack (TIA) or Stroke Trial N/A
Completed NCT00597974 - Neurological Outcome With Carotid Artery Stenting N/A
Completed NCT00211731 - Preventing Recurrent Stroke in Minority Populations N/A
Active, not recruiting NCT03635749 - Intensive Medical Therapy for High-risk Intracranial or Extracranial Atherosclerosis Phase 3
Completed NCT03153020 - Determinants of Adherence to Post-stroke/Transient Ischemic Attack Secondary Prevention Treatment: Cohort Study in the Rhône
Recruiting NCT04075500 - Optimal Detection of Atrial Fibrillation in TIA N/A
Recruiting NCT06091319 - Florbetaben for Imaging of Vascular Amyloid
Completed NCT04604015 - RoBotic TCD Ultrasound BubbLe Study Compared to Transthoracic Echocardiography for Detection of Right to Left Shunt N/A
Completed NCT00885456 - Program of Rehabilitative Exercise and Education to Avert Vascular Events After Non-disabling Stroke or Transient Ischemic Attack: A Multi-site RCT Phase 2
Recruiting NCT05620966 - EEG to Diagnose TIA and Stroke